Home Micro Medical Solutions

Micro Medical Solutions

2.5mm MicroStent and MicroBalloon XL Receive CE Mark Reports Micro Medical Solutions

The 2.5 mm MicroStent vascular stent, is the smallest diameter MicroStent to date. Also granted CE Mark approval is the long (120 cm) over-the-wire balloon catheter, MicroBalloon XL.

FDA IDE Approval for Pivotal Clinical Trial of MicroStent

IDE approval allows the company to initiate a U.S. pivotal clinical trial to evaluate MicroStent’s safety and efficacy. MicroStent has already obtained CE Mark approval for use in the EU. MicroStent is a vascular stent specifically designed to achieve and maintain vessel patency and improve blood flow in order to reduce below-the-knee amputations for patients with critical limb ischemia (CLI) resulting from peripheral artery disease (PAD). Last fall, MMS completed a 3-center, 15-patient feasibility study of MicroStent in which MicroStent met all primary endpoints for both safety and efficacy.

Micro Medical Solutions’ New MicroStent with 120 cm Delivery Catheter Receives CE Mark Approval

11/5/18: With a longer, more robust access system and new stent sizes, physicians have more options to access and open arteries affected by critical limb ischemia and prevent lower-leg amputations.

International Scientific Advisory Board Announced by Micro Medical Solutions

4/26/18: To accelerate study of the MicroStent microvascular device and other new technologies designed to prevent amputation, MMS has assembled six world leaders in treating peripheral artery disease and critical limb ischemia.